Journals / Journal of Surgery and Medicine / 2020 / Cilt: 4 - Sayı: 12

Effects of contraception methods on female sexual function and quality of life

Kontrasepsiyon yöntemlerinin kadın cinsel fonksiyonu ve yaşam kalitesi üzerindeki etkisi

Pages
1231–1235
Publication Date
2020-12-01
DOI
—
🏛️Bibliographic metadata and full text access for this article are provided via DergiPark.
DergiPark Record ↗
✨

AI Summary & Key Takeaways

AI Insight
⚡ TL;DR(Too Long; Didn't Read)

FSFI scores of the patients using and not using contraceptive methods were significantly different (P

📌 3 Key Takeaways

🎯
Objective & Hypothesis:Aim: Many women of reproductive age who use contraceptive methods have sexual dysfunction and reduced quality of life.
📊
Key Findings & Data:This study aimed to evaluate the effects of various contraceptive methods on female sexual function index (FSFI) and quality of life scale (SF-12).
💡
Conclusion & Impact:FSFI scores of the patients using and not using contraceptive methods were significantly different (P
🔬Design:Research Article
📍Scope:2020 Verileri
⚙️Variables:Kadın cinsel fonksiyon bozukluğu · Yaşam kalitesi · Doğum kontrolü

Abstract

Aim: Many women of reproductive age who use contraceptive methods have sexual dysfunction and reduced quality of life. This study aimed to evaluate the effects of various contraceptive methods on female sexual function index (FSFI) and quality of life scale (SF-12). Methods: This prospective observational study was conducted on the patients admitted to the Gynecology and Obstetrics outpatient clinic between August and October 2020. FSFI total score and FSFI sub-domains (desire, arousal, lubrication, orgasm, satisfaction, and pain) and SF- 12 were used to compare the differences between the groups using various contraceptive methods (Mirena, Copper RIA, tubal ligation, condom, and oral contraceptive pill). The demographic characteristics of the patients, the FSFI, and SF-12 data were collected by the researchers face to face. Results: A total of 228 subjects with a mean age of 30.32 years participated in the study. FSFI scores of the patients using and not using contraceptive methods were significantly different (P

Özet

Amaç: Bu çalışmamızda, kontrasepsiyon yöntemlerinin kadın cinsel fonksiyonuna ve yaşam kalitesine etkisinin, Kadın Cinsel Fonksiyon Ölçeği (KCFÖ) ve Yaşam Kalitesi Ölçeği (SF-12) doğrultusunda ölçülmesi amaçlandı. Yöntemler: Bu prospektif gözlemsel araştırmaya, Ağustos-Ekim 2020 tarihleri arasında Kadın hastalıkları ve doğum polikliniğimize başvuran hastalar dahil edildi. KCFÖ ve alt grupları skorları (arzu, uyarılma, lubrikasyon, orgasm, memnuniyet ve ağrı ) ile SF-12 skorları korunma yöntemleri (Mirena, Bakır RIA, tüp ligasyonu, kondom, ve oral kontraseptif hap) kullananlar ile kullanmayanların cinsel işlevleri ve yaşam kaliteleri açısından farklılık olup olmadığını araştırmak amacıyla kullanıldı. Hastaların demografik özellikleri, KCFÖ ve SF-12 skorları araştırmacılar tarafından yüz yüze toplandı. Bulgular: Çalışmaya 228 kişi dahil edildi, çalışmaya katılan kadınların ortalama yaşı 30,32 saptandı. Toplam KCFÖ skoru bakımından, gruplar arasında istatistiksel olarak anlamlı bir fark söz konusudur (P

🔖

Cite This Article

GÜRBÜZ, T., GÜNGÖR, N. D., OKÇU, N. T., YURCİ, A. (2020). Effects of contraception methods on female sexual function and quality of life. Journal of Surgery and Medicine, Cilt: 4 - Sayı: 12, 1231–1235. https://ajindex.com/articles/780168

📄 Full Text PDF Viewer

📄

PDF görüntüleyici hazırlanıyor...

References (15)

  1. Sakinci M, Ercan CM, Olgan S, Coksuer H, Karasahin KE, Kuru O. Comparative analysis of copper intrauterine device impact on female sexual dysfunction subtypes. Taiwan J Obstet Gynecol. 2016;55(03):460-1
  2. Kütmeç C. Kadınlarda cinsel fonksiyon bozukluğu ve hemşirelik bakımı. Fırat Sağlık Hizmetleri Dergisi. 2009;4(12):111-36
  3. Kingsberg S, Woodard T. Female sexual dysfunction: focus on low desire. Obstet Gynecol. 2015;125(2):477-86
  4. Shifren JL, Monz BU, Russo PA, Segreti A, Johannes CB. Sexual problems and distress in United States women:prevalence and correlates. Obstet Gynecol. 2008;112(5):970-8
  5. Kohn IJ, Kaplan SA. Female sexual dysfunction: What is known and what remains to be determined. Contemporary Urology 1999;9:54-72
  6. Rosen RC, Taylor JF, Leiblum SR, Bachmann GA. Prevalence of sexual dysfunction in women:results of a survey study of 329 women in an outpatient gynecological clinic. J Sex Marital Ther. 1993;19(3):171-88
  7. Aygin D, Aslan FE. Turkish adaptation of the Female Sexual Function Index. Türkiye Klinikleri. J Med Sci.2005;25(3):393-99
  8. Biddle AK, West SL, D'Aloisio AA, Wheeler SB, Borisov NN, Thorp J. Hypoactive sexual desire disorder in postmenopausal women:quality of life and health burden. Value Health. 2009;12(5):763-72
  9. Lewis RW, Fugl-Meyer KS, Bosch R, Fugl-Meyer AR, Laumann EO, Lizza E, et al. Epidemiology/risk factors of sexual dysfunction. J Sex Med 2004;1(1):35-9
  10. Li RH, Lo SS, Teh DK, Tong NC, Tsui MH, Cheung KB, et al. Impact of common contraceptive methods on quality of life and sexual function in Hong Kong Chinese women. Contraception. 2004;70(60):474-82
  11. Sadatmahalleh SJ, Ziaei S, Kazemnejad A, Mohamadi E. Evaluation of sexual function and quality of life in Iranian women with tubal ligation: a historical cohort study. Int J Impot Res. 2015;27(5):173–7
  12. Smith A, Lyons A, Ferris J, Richters J, Pitts M, Shelley J. Are sexual problems more common in women who have had a tubal ligation? A population-based study of Australian women. BJOG. 2010;117(4):463–8
  13. Skrzypulec V, Drosdzol A. Evaluation of quality of life and sexual functioning of women using levonorgestrel-releasing intrauterine contraceptive system Mirena. Coll Antropol. 2008;32(4):1059-68
  14. Laumann EO, Paik A, Rosen RC. Sexual dysfunction in the United States: prevalence and predictors. JAMA. 1999;281(6):537-44
  15. Rosen R, Brown C, Heiman J, Leiblum S, Meston C, Shabsigh R, et al. The Female Sexual Function Index (FSFI):a multid